Research and Development

MPS has extended its range of child resistant packs. These patented designs offer maximum flexibility and can be customised to …

MSD, known as Merck in North America, has launched a bold move by filing Keytruda, and being accepted, for Priority …

Technology firm Philips and biotech Illumina have announced they are to partner up in collaboration which plans to marry the …

As part of the wider ‘cancer moonshot’ initiative, confirmed by the signing of the 21st Century Cures Act by Obama, …

Japanese pharma firm Daiichi Sankyo has announced its intention to close its R&D centre in Gurgaon, India, a step in …

The FDA regulator has publicly announced that there are safety issues with certain of St. Jude’s medical devices, including cardiac …

As a forward-looking company with extensive knowledge and experience, SHL delivers solutions for today on the path to tomorrow. This …

Studies at the Icahn School of Medicine in New York City and the University of Regensburg in Germany have found …

Egalet has gained FDA approval for Arymo ER, a long-acting opioid painkiller that is made to be difficult to breakdown. …

Researchers at King’s College London have discovered a novel use of a drug to treat Alzheimer’s disease, finding that the …

Happy New Year from us here at Pharmafocus! As we leave 2016 behind, take a look at ten of its …

Amgen has announced it is to join forces with cancer immunotherapy biotech Immatics Biotechnologies in a partnership potentially worth over …

Erik Digman Wiklund has been named as the new chief financial officer (CFO) of Norwegian biotech Targovax, replacing Oystein Soug …

Pfizer has released the successful Phase 3 results to its biosimilar to AbbVie’s blockbuster Humira, meeting its primary endpoint in …

Ionis Pharmaceuticals and one of its wholly-owned subsidiaries Akcea Therapeutics have entered into a partnership with Novartis worth potentially more …